v3.24.2.u1
Schedule of Restatement of Consolidated Balance Sheet (Details) - USD ($)
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Current assets            
Cash   $ 3      
Prepaid expenses 4,822   1,529      
Total Current Assets 4,822   1,532      
Equipment, net (Note 4) 417   667      
Total assets 5,239   2,199      
Current liabilities            
Accounts payable and accrued liabilities 67,956   62,387      
Total liabilities 2,125,513   1,837,103      
Stockholders’ deficit            
Preferred stock, 5,000,000 shares authorized, $0.000001 par value 2 shares issued and outstanding 1   1      
Common stock, 500,000,000 shares authorized, $0.000001 par value 131,903,029 issued and outstanding (December 31, 2022 – 131,903,029) 132   132      
Additional paid-in capital 10,187,703   10,000,348      
Deficit (12,308,110)   (11,835,385)      
Total stockholders’ deficit (2,120,274) $ (1,979,859) (1,834,904) $ (1,532,332) $ (1,381,302) $ (1,238,891)
Total liabilities and stockholders’ deficit 5,239   2,199      
Related Company [Member]            
Current liabilities            
Due to related parties 41,273   41,273      
Related Party [Member]            
Current liabilities            
Due to related parties $ 2,016,284   $ 1,733,443      
Previously Reported [Member]            
Current assets            
Cash          
Prepaid expenses       4,647    
Total Current Assets       4,647    
Equipment, net (Note 4)       917    
Total assets       5,564    
Current liabilities            
Accounts payable and accrued liabilities       48,388    
Investment in partnership, related (Note 3)       42,732    
Total liabilities       1,580,628    
Stockholders’ deficit            
Preferred stock, 5,000,000 shares authorized, $0.000001 par value 2 shares issued and outstanding       1    
Common stock, 500,000,000 shares authorized, $0.000001 par value 131,903,029 issued and outstanding (December 31, 2022 – 131,903,029)       132    
Additional paid-in capital       10,000,348    
Deficit       (11,575,545)    
Total stockholders’ deficit       (1,575,064)    
Total liabilities and stockholders’ deficit       5,564    
Previously Reported [Member] | Related Company [Member]            
Current liabilities            
Due to related parties       42,303    
Previously Reported [Member] | Related Party [Member]            
Current liabilities            
Due to related parties       1,447,205    
Revision of Prior Period, Reclassification, Adjustment [Member]            
Current assets            
Cash          
Prepaid expenses          
Total Current Assets          
Equipment, net (Note 4)          
Total assets          
Current liabilities            
Accounts payable and accrued liabilities          
Investment in partnership, related (Note 3)       (42,732)    
Total liabilities       (42,732)    
Stockholders’ deficit            
Preferred stock, 5,000,000 shares authorized, $0.000001 par value 2 shares issued and outstanding          
Common stock, 500,000,000 shares authorized, $0.000001 par value 131,903,029 issued and outstanding (December 31, 2022 – 131,903,029)          
Additional paid-in capital          
Deficit       42,732    
Total stockholders’ deficit       42,732    
Total liabilities and stockholders’ deficit          
Revision of Prior Period, Reclassification, Adjustment [Member] | Related Company [Member]            
Current liabilities            
Due to related parties          
Revision of Prior Period, Reclassification, Adjustment [Member] | Related Party [Member]            
Current liabilities            
Due to related parties          
Restated [Member]            
Current assets            
Cash          
Prepaid expenses       4,647    
Total Current Assets       4,647    
Equipment, net (Note 4)       917    
Total assets       5,564    
Current liabilities            
Accounts payable and accrued liabilities       48,388    
Investment in partnership, related (Note 3)          
Total liabilities       1,537,896    
Stockholders’ deficit            
Preferred stock, 5,000,000 shares authorized, $0.000001 par value 2 shares issued and outstanding       1    
Common stock, 500,000,000 shares authorized, $0.000001 par value 131,903,029 issued and outstanding (December 31, 2022 – 131,903,029)       132    
Additional paid-in capital       10,000,348    
Deficit       (11,532,813)    
Total stockholders’ deficit       (1,532,332)    
Total liabilities and stockholders’ deficit       5,564    
Restated [Member] | Related Company [Member]            
Current liabilities            
Due to related parties       42,303    
Restated [Member] | Related Party [Member]            
Current liabilities            
Due to related parties       $ 1,447,205